Legal Victory Boosts Prospects for Hims & Hers in Weight-Loss Drug Market

A landmark court decision has removed the most significant legal threat facing the rapidly expanding market for affordable weight-loss medications. This development delivered a substantial victory for telehealth providers and provided a notable lift to shares of Hims & Hers Health, as pharmaceutical giants Eli Lilly and Novo Nordisk suffered a decisive courtroom defeat in their ongoing legal campaign.

A U.S. federal court dismissed a lawsuit brought by Eli Lilly against telehealth provider Willow Health, which operates on a business model comparable to Hims. Presiding Judge Andre Birotte Jr. found no evidence of widespread patient harm and underscored that prescription medications are administered under physician supervision. This ruling effectively clarifies the legality of personalized GLP-1 medication programs Read more...